Comparison between VDR analogs and current immunosuppressive drugs in relation to CXCL10 secretion by human renal tubular cells.
Sagrinati
Costanza
C
Excellence Center for Research, Transfer and High Education (DENOthe), University of Florence, Florence, Italy.
Sottili
Mariangela
M
Mazzinghi
Benedetta
B
Borgogni
Elisa
E
Adorini
Luciano
L
Serio
Mario
M
Romagnani
Paola
P
Crescioli
Clara
C
D000328:Adult; D002117:Calcitriol / Q000031:analogs & derivatives* / Q000494:pharmacology; D002478:Cells, Cultured; D054357:Chemokine CXCL10 / Q000096:biosynthesis* / Q000187:drug effects / Q000235:genetics; D004797:Enzyme-Linked Immunosorbent Assay; D005786:Gene Expression Regulation / Q000187:drug effects*; D006084:Graft Rejection / Q000378:metabolism / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology*; D016030:Kidney Transplantation; D007684:Kidney Tubules / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D012313:RNA / Q000235:genetics*; D018167:Receptors, Calcitriol / Q000819:agonists*; D012016:Reference Values
C487049:BXL628; C114753:CXCL10 protein, human; D054357:Chemokine CXCL10; D007166:Immunosuppressive Agents; D018167:Receptors, Calcitriol; D012313:RNA; D002117:Calcitriol